All articles by GlobalData Healthcare

  1. Risk of developing generalised MG is higher in smokers

    Smoking was long suspected as increasing the risk of generalised Myasthenia gravis (MG). However, there was no conclusive evidence until…
    Read More…

    11 Oct
  2. Could anti-coagulants be the key to treating Alzheimer’s disease?

    The need for new disease-modifying drugs (DMDs) is urgent as the current competitive landscape in Alzheimer’s disease (AD) only offers…
    Read More…

    10 Oct
  3. Amgen enters partnership to use adaptive biotechnologies’ MRD diagnostic assay for haematology drug development

    On 17 September, Adaptive Biotechnologies announced it had entered into a global agreement with Amgen to use its clonoSEQ Assay…
    Read More…

    9 Oct
  4. Improvements to joints and skin see Taltz outscore Humira

    Improvements to joints and skin were key factors in deciding the winner of a year long psoriatic arthritis (PsA) drugs…
    Read More…

    9 Oct
  5. IDWeek 2019: New clinical studies promise more treatment options for influenza infections

    During the last day at IDWeek 2019 in Washington DC, Flor Munoz from the Baylor College of Medicine in Houston,…
    Read More…

    9 Oct
  6. Should breast cancer screening become routine in high-risk men?

    Male breast cancer is rare but often deadly. The American Cancer Society estimates that 2,670 new cases of invasive breast…
    Read More…

    8 Oct
  7. Are we entering the era of novel inhaled phosphodiesterase inhibitors?

    With little low-hanging fruit remaining, therapies with novel mechanisms of actions are highly prized, therefore, when the inhaled phosphodiesterase-4 inhibitor…
    Read More…

    8 Oct
  8. Rituxan gains label expansion to two rare forms of pediatric vasculitis

    On 30 September the US Food and Drug Administration (FDA) approved F. Hoffmann-La Roche’s Rituxan (rituximab) for the treatment of…
    Read More…

    7 Oct
  9. Sanofi’s Dengvaxia in the Philippines: a comedy or tragedy of errors?

    Dengue fever is a mosquito-borne, hemorrhagic infection affecting between 50 and 500 million patients globally every year. While Dengue fever…
    Read More…

    4 Oct
  10. ‘Painful’ 2020 Russian regulations will make EU rules ‘look like a walk in the park’

    Russian serialisation regulations will go into effect on 1 January 2020, and cover all prescription and over-the-counter medicines manufactured within…
    Read More…

    4 Oct
Close
Close
Close

Go Top